{"id":1139,"date":"2026-06-09T10:00:00","date_gmt":"2026-06-09T10:00:00","guid":{"rendered":"https:\/\/medycyna-gorska.pl\/?p=1139"},"modified":"2026-06-09T10:21:58","modified_gmt":"2026-06-09T10:21:58","slug":"pre-expedition-medical-preparation","status":"publish","type":"post","link":"https:\/\/medycyna-gorska.pl\/en\/pre-expedition-medical-preparation\/","title":{"rendered":"Pre-Expedition Medical Preparation \u2014 Tests, Vaccines, Training"},"content":{"rendered":"\n

Pre-expedition medical preparation for high-altitude trips<\/strong> is not a single visit to your family doctor the week before departure. It is a 3\u20136 month process covering baseline testing, vaccinations, chronic medication decisions, planning for comorbidities, and often a conversation about whether this particular expedition is safe for you. This guide provides: a complete 6-month pre-departure checklist, which tests to do (and which to skip), which vaccines are really needed for Nepal and Tanzania, and how to discuss diabetes, asthma, or hormonal contraception in the context of 6000 m.<\/p>\n\n\n\n

Six-month pre-expedition checklist<\/h2>\n\n\n\n
    \n
  1. 6 months before:<\/strong> consultation with expedition\/travel medicine physician; start endurance training<\/li>\n
  2. 4 months before:<\/strong> baseline tests (blood work, resting ECG); dental review; specialist consultations for chronic diseases<\/li>\n
  3. 3 months before:<\/strong> first vaccinations (Hep A+B \u2014 0\/1\/6 mo schedule); prescriptions for rescue drugs (acetazolamide, dexamethasone, nifedipine)<\/li>\n
  4. 2 months before:<\/strong> second vaccinations (typhoid, meningococcal); hypoxia test if indicated; insurance with helirescue<\/li>\n
  5. 6 weeks before:<\/strong> stress ECG (if >40 yrs or risk factors); last high-intensity training session<\/li>\n
  6. 4 weeks before:<\/strong> complete medical kit; check weight, blood pressure, wellbeing; intense aerobic base period<\/li>\n
  7. 2 weeks before:<\/strong> taper rest, avoid infections, final consultations<\/li>\n
  8. 1 week before:<\/strong> equipment list, dental visit if any doubts, test medical gear (pulse oximeter, headlamp, AED if you have one)<\/li>\n<\/ol>\n\n\n\n

    Baseline tests \u2014 what’s actually worth doing<\/h2>\n\n\n\n

    Basic panel<\/h3>\n\n\n\n
      \n
    • Complete blood count<\/strong> \u2014 especially Hb (normal >12 g\/dL women, >13 g\/dL men); low Hb combined with high expedition activity drastically shortens tolerance<\/li>\n
    • Fasting glucose + HbA1c<\/strong> \u2014 rules out undiagnosed diabetes<\/li>\n
    • Creatinine + eGFR<\/strong> \u2014 acetazolamide requires eGFR >30 mL\/min; many rescue drugs cannot be used in renal insufficiency<\/li>\n
    • Liver enzymes (ALT, AST)<\/strong><\/li>\n
    • TSH<\/strong> \u2014 hypothyroidism is a common unrecognized cause of fatigue, amplified at altitude<\/li>\n
    • Urinalysis<\/strong><\/li>\n
    • Resting ECG<\/strong> \u2014 mandatory for all >35 yrs<\/li>\n<\/ul>\n\n\n\n

      Extended tests (conditional)<\/h3>\n\n\n\n
        \n
      • Stress ECG (exercise test)<\/strong> \u2014 >40 yrs, family history of cardiac disease, hypertension, diabetes, smoking<\/li>\n
      • Spirometry<\/strong> \u2014 history of asthma or smoking<\/li>\n
      • Cardiopulmonary exercise testing (VO2max)<\/strong> \u2014 optional for those planning very high peaks; gives an objective measure of aerobic capacity<\/li>\n
      • Echocardiography<\/strong> \u2014 hypertension, prior arrhythmias, cardiac murmurs<\/li>\n
      • Hypoxia Altitude Simulation Test (HAST)<\/strong> \u2014 for asthma, COPD, cardiac disease; tests hypoxia tolerance by simulating FiO\u2082 15% (equivalent to 2500 m)<\/li>\n<\/ul>\n\n\n\n

        Hypoxia test \u2014 is it worth it?<\/h2>\n\n\n\n

        HAST<\/strong> involves breathing a 15% O\u2082 mixture for 20 minutes while monitoring saturation, heart rate, ECG, and symptoms. It simulates conditions at 2500 m \u2014 the threshold above which AMS becomes realistic in susceptible individuals.<\/p>\n\n\n\n

        When HAST makes sense:<\/p>\n\n\n\n

          \n
        • Patient with asthma, COPD, pulmonary hypertension<\/li>\n
        • History of HAPE\/HACE without clear cause (fast ascent)<\/li>\n
        • Planned expedition >5000 m in person without prior high-altitude experience<\/li>\n
        • Aviation \/ high-altitude rescue work (service protocols)<\/li>\n<\/ul>\n\n\n\n

          Limitations: HAST predicts short-term tolerance but does not predict AMS\/HAPE\/HACE development<\/strong> over 24\u201372 h of actual acclimatization. A positive result does not exempt from the 300\u2013500 m rule.<\/p>\n\n\n\n

          Vaccinations by destination<\/h2>\n\n\n\n

          Nepal (EBC, Annapurna, Manaslu)<\/h3>\n\n\n\n
            \n
          • Hepatitis A + B<\/strong> (combined TwinRix: 0\/1\/6 mo, or 0\/7\/21 days with 12-mo booster)<\/li>\n
          • Typhoid<\/strong> (Typhim Vi \u2014 1 dose, 3-year protection)<\/li>\n
          • Cholera<\/strong> (Dukoral \u2014 2 doses 1\u20136 weeks apart) \u2014 recommended for long expeditions<\/li>\n
          • Meningococcal ACWY<\/strong> \u2014 especially if staying in lodges with many people<\/li>\n
          • Pre-exposure rabies<\/strong> (3 doses in 0\/7\/21 days) \u2014 consider; immunoglobulin availability in Nepal is limited<\/li>\n
          • Japanese encephalitis<\/strong> (Ixiaro \u2014 2 doses) \u2014 only if plan includes lowland Terai during monsoon<\/li>\n
          • Tetanus + diphtheria + pertussis<\/strong> \u2014 booster every 10 years<\/li>\n<\/ul>\n\n\n\n

            Tanzania (Kilimanjaro, Serengeti safari)<\/h3>\n\n\n\n
              \n
            • Hepatitis A + B<\/strong> (TwinRix)<\/li>\n
            • Typhoid<\/strong><\/li>\n
            • Yellow fever<\/strong> (Stamaril \u2014 1 dose, lifetime validity since 2016) \u2014 MANDATORY for entry to Tanzania from at-risk-zone countries<\/strong><\/li>\n
            • Malaria \u2014 pharmacological prophylaxis<\/strong>: atovaquone + proguanil (Malarone) 1 tablet daily; start 1\u20132 days before, continue 7 days after return. Alternative: doxycycline 100 mg\/day (cheaper, phototoxic)<\/li>\n
            • Meningococcal ACWY<\/strong> \u2014 mandatory on some safari routes in the “meningitis belt”<\/li>\n
            • Pre-exposure rabies<\/strong> \u2014 consider<\/li>\n<\/ul>\n\n\n\n

              South America (Peru, Argentina \u2014 Cordillera, Aconcagua)<\/h3>\n\n\n\n
                \n
              • Hepatitis A + B<\/strong><\/li>\n
              • Typhoid<\/strong><\/li>\n
              • Yellow fever<\/strong> \u2014 mandatory for some parts of Peru (Amazon); not required for typical high-altitude routes but a good option<\/li>\n
              • Rabies<\/strong> \u2014 consider<\/li>\n
              • Malaria is usually not a risk above 2500 m \u2014 unless plan includes lowlands<\/li>\n<\/ul>\n\n\n\n

                Chronic disease protocols<\/h2>\n\n\n\n

                Hypertension<\/h3>\n\n\n\n

                Altitude causes physiological blood pressure rise (sympathetic activation + polycythemia). For controlled hypertension: continue medications, monitor BP morning and evening. Caution with beta-blockers<\/strong> \u2014 they reduce aerobic exercise tolerance at altitude. ACE inhibitors\/ARBs<\/strong> and calcium channel blockers<\/strong> are better for “high-altitude” patients.<\/p>\n\n\n\n

                Type 1 and type 2 diabetes<\/h3>\n\n\n\n

                Altitude changes insulin absorption (cold = slower subcutaneous absorption) and energy demands (increased 30\u201350% above 4000 m). Type 1: intensive glucose monitoring, adjusted short- and long-acting insulin doses, glucagon reserve, warm insulin storage. Type 2 on metformin: theoretical increased risk of lactic acidosis at altitude, consider a break after diabetology consultation.<\/p>\n\n\n\n

                Asthma<\/h3>\n\n\n\n

                Exercise-induced asthma and cold are a common combination at altitude. Carry 2\u00d7 the medication you’d need at home (short-acting beta-agonist, inhaled steroid). Avoid dust (buff!), do peak flow monitoring morning and evening. For severe asthma: HAST before expedition is mandatory.<\/p>\n\n\n\n

                Cardiac disease<\/h3>\n\n\n\n

                Uncontrolled heart failure, recent myocardial infarction (<6 mo), unstable coronary disease, severe aortic stenosis \u2014 contraindications to expeditions >3500 m<\/strong>. Stable coronary disease after revascularization (>6 mo) may be acceptable after cardiology consultation + exercise test + possibly control angiography.<\/p>\n\n\n\n

                Women \u2014 menstrual cycle, contraception<\/h2>\n\n\n\n

                Hormonal contraception and thrombosis risk<\/h3>\n\n\n\n

                Altitude increases deep vein thrombosis (DVT) and pulmonary embolism risk through combination: polycythemia (thicker blood), dehydration, long hours of immobility (flights, lodges). Estrogen contraception adds another 3\u20134\u00d7 increased risk. Consider:<\/p>\n\n\n\n

                  \n
                • Temporary switch to estrogen-free contraception (progestogen-only \u2014 Cerazette, Slinda)<\/li>\n
                • Hormonal IUD (Mirena) \u2014 no systemic estrogen<\/li>\n
                • Non-hormonal methods during expedition<\/li>\n
                • Gynecologist consultation minimum 3 months before<\/li>\n<\/ul>\n\n\n\n

                  Menstrual management on expedition<\/h3>\n\n\n\n

                  Menstruation in expedition conditions is not a “delicate matter” \u2014 it is a real logistical problem. Options:<\/p>\n\n\n\n

                    \n
                  • Cycle deferral<\/strong> \u2014 continuous use of combined contraception (skip 7-day pause) or progestogen preparations. Consult gynecologist.<\/li>\n
                  • Menstrual cup<\/strong> \u2014 doesn’t require running water, used 8\u201312 h continuously<\/li>\n
                  • Tampons + pad supply<\/strong> \u2014 mass to carry (~50 g per expedition day)<\/li>\n
                  • Period underwear<\/strong> (Thinx, Modibodi) \u2014 washable, dries in tent<\/li>\n<\/ul>\n\n\n\n

                    Insurance with helirescue \u2014 7 check points<\/h2>\n\n\n\n
                      \n
                    1. Maximum altitude<\/strong> covered \u2014 many policies exclude >4500 m or require surcharge<\/li>\n
                    2. Helicopter evacuation limit<\/strong> \u2014 minimum 15,000 EUR (Himalayan evacuation cost 3000\u20135000 USD + Kathmandu hospitalization)<\/li>\n
                    3. Overseas hospitalization coverage<\/strong> \u2014 minimum 50,000 EUR<\/li>\n
                    4. Extension for “high-altitude mountaineering” or “high-altitude trekking”<\/strong><\/li>\n
                    5. Claim procedure<\/strong> \u2014 24\/7 helpline, not e-mail delayed response<\/li>\n
                    6. Mountaineering equipment<\/strong> \u2014 does it cover loss\/damage (crampons, ice axe, harness can be costly)<\/li>\n
                    7. Trip cancellation conditions<\/strong> \u2014 for medical reasons before departure<\/li>\n<\/ol>\n\n\n\n

                      Recommended providers: World Nomads, Global Rescue, SafetyWing, IMG (Alps). Read the fine print thoroughly.<\/p>\n\n\n\n

                      Frequently asked questions<\/h2>\n\n\n
                      \n
                      \n
                      \n

                      What tests before Kilimanjaro?<\/h3>\n
                      \n\n

                      Minimum panel for healthy person: CBC, glucose, creatinine, resting ECG. For >35 yrs or risk factors: stress ECG. Spirometry if asthma history. For chronic diseases (diabetes, hypertension, asthma) \u2014 consult appropriate specialist. Start 3\u20134 months before \u2014 tests rarely need repeating but results must be discussed and medications planned.<\/p>\n\n<\/div>\n<\/div>\n

                      \n

                      Does hypoxia test predict AMS?<\/h3>\n
                      \n\n

                      Partially. HAST (Hypoxia Altitude Simulation Test) shows short-term hypoxia tolerance (20 min at 15% O\u2082) and is useful for asthma, COPD, uncontrolled heart failure. Does not predict whether you’ll develop AMS\/HAPE\/HACE during 24\u201372 h real acclimatization. A positive HAST does not exempt from the 300 m\/day rule.<\/p>\n\n<\/div>\n<\/div>\n

                      \n

                      Does diabetes exclude expedition to 6000 m?<\/h3>\n
                      \n\n

                      No, but requires intensive preparation. Well-controlled type 1 (HbA1c <7, no end-organ damage) can participate provided: diabetology consultation, insulin protocol accounting for cold storage and increased energy demand, glucagon reserve, intensive glucose monitoring (CGM very valuable here). Type 2 on metformin \u2014 individual consultation, consider break.<\/p>\n\n<\/div>\n<\/div>\n

                      \n

                      Hormonal contraception and altitude \u2014 thrombosis risk?<\/h3>\n
                      \n\n

                      Baseline thrombosis risk with combined oral contraception (with estrogen) is 2\u20133\u00d7 vs non-users. Altitude adds further risk through polycythemia and dehydration. Reasonable strategy: switch 3 months before to estrogen-free contraception (progestogen-only pills, IUD) or temporarily to non-hormonal methods. Consult gynecologist.<\/p>\n\n<\/div>\n<\/div>\n

                      \n

                      When to start vaccinations before Nepal?<\/h3>\n
                      \n\n

                      3\u20136 months before departure. Classic Hep A+B (TwinRix) schedule: 0, 1, 6 months \u2014 requires 6 mo. Accelerated schedule: 0, 7, 21 days + 12-mo booster \u2014 possible with less time. Typhoid \u2014 1 dose minimum 2 weeks before. Meningococcal ACWY \u2014 1 dose min 2 weeks before. Pre-exposure rabies (if elected) \u2014 3 doses over 21 days, complete at least a month before.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n

                      References<\/h2>\n\n\n\n
                        \n
                      • Luks AM, Swenson ER, B\u00e4rtsch P. Acute high-altitude sickness<\/em>. Eur Respir Rev. 2017;26(143):160096.<\/li>\n
                      • CDC Yellow Book 2024 \u2014 Travel Recommendations.<\/li>\n
                      • Wilkes M, MacInnis MJ, Hillebrandt D. Traveling to high altitude with pre-existing diseases<\/em>. Br J Gen Pract. 2016;66(644):138\u2013139.<\/li>\n
                      • Pollard AJ, Niermeyer S, Barry P, et al. Children at high altitude: international consensus statement<\/em>. High Alt Med Biol. 2001;2(3):389\u2013403.<\/li>\n<\/ul>\n\n\n\n

                        Disclaimer:<\/strong> This article is informational and does not replace individual consultation with an expedition or travel medicine physician. The medical plan must be tailored to a specific route, duration, and comorbidities.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"

                        Full medical checklist 6 months before high-altitude expeditions. Hypoxia testing, vaccines, chronic disease protocols, contraception, helirescue insurance.<\/p>\n","protected":false},"author":2,"featured_media":1245,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktualnosci"],"_links":{"self":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/comments?post=1139"}],"version-history":[{"count":2,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1139\/revisions"}],"predecessor-version":[{"id":1287,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1139\/revisions\/1287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media\/1245"}],"wp:attachment":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media?parent=1139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/categories?post=1139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/tags?post=1139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}